학술논문
Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: Findings from a non-interventional, real-world data safety study
Document Type
ConferencePaper
Author
Source
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 30:85-85
Subject
Language
English
English
English
ISSN
1053-8569